# A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer

> **NCT01890096** · PHASE2 · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 174 (estimated)

## Conditions studied

- Carcinoma of the Prostate

## Interventions

- **RADIATION:** HDR 2 Fraction
- **RADIATION:** HDR 1 Fraction

## Key facts

- **NCT ID:** NCT01890096
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2017-05-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2018-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01890096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01890096, "A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01890096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*